Since the patent for semaglutide, the key ingredient in weight loss drugs, expired in March, prices in India have fallen 80%
If additional weight reduction is needed in patients with type 2 diabetes mellitus treated with WEGOVY 25 mg tablets, consider switching to WEGOVY 1.7 mg injection and follow the recommended dosage escalation for WEGOVY injection [see Dosage and Administration (2.2), Use in Specific Populations (8.6), Clinical Pharmacology (12.3)]
The most common were nausea, vomiting and constipation, which aligned with what clinical trials found, according to Sehgal
[DOI] [PMC free article] [PubMed] [Google Scholar] 29.Sorli C., Harashima S.I., Tsoukas G.M., Unger J., Karsbl J.D., Hansen T., Bain S.C